Skip to main content
. 2015 May 1;8(5):5403–5410.

Table 3.

Clinical information of patients with Xp11.2 RCC treated by tumor enucleation (TE)

Case Gender Age (years) Tumor site Greatest diameter (cm) Stage Operative method Follow up (months) outcome
1 Female 30 Right 3.2 T1aM0N0 Radiofrequency ablation assisted enucleation 44 without recurrence
2 Male 29 Left 3.5 T1aM0N0 TE 11 without recurrence
3 Female 51 Right 5.0 T1bM0N0 TE 34 without recurrence